Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma

被引:6
作者
Hernandez-Guerrero, T. [1 ]
Doger, B. [1 ]
Moreno, V [1 ]
机构
[1] Fdn Jimenez Diaz Univ Hosp, Madrid, Spain
关键词
Cemiplimab; Anti-PD-1; therapy; Cancer immunotherapy; Immune checkpoint inhibitors; Mutational burden; Squamous cell carcinoma; Skin cancer; Nonmelanoma skin cancer; Monoclonal antibodies; MUTATIONAL LANDSCAPE; PD-1; BLOCKADE; MOHS SURGERY; BASAL-CELL; METASTASIS; RECURRENCE; SKIN; BIOMARKER; THERAPY; DISEASE;
D O I
10.1358/dot.2019.55.8.3005176
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent type of malignancy in Caucasians worldwide. Several factors have been correlated with aggressiveness and likelihood of recurrence and distant metastases, which are challenging to control. Metastatic disease has a dismal prognosis, and standard chemotherapy has failed to significantly improve outcomes. Recently, it has been recognized that cSCCs are highly mutated tumors with a denoting potential likelihood of response to immune checkpoint blockade. Cemiplimab is an anti-programmed cell death protein 1 (PD-1) antibody recently approved for the treatment of unresectable locally advanced or metastatic cSCC by the U.S. Food and Drug Administration (FDA) and the European Commission with a compelling response rate and an acceptable safety profile.
引用
收藏
页码:485 / 494
页数:10
相关论文
共 41 条
[1]   Therapy of Advanced Squamous Cell Carcinoma of the Skin [J].
Bejar, Claudia ;
Maubec, Eve .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (02) :302-320
[2]   Mohs Surgery for Squamous Cell Carcinoma [J].
Belkin, Daniel ;
Carucci, John A. .
DERMATOLOGIC CLINICS, 2011, 29 (02) :161-+
[3]   Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice [J].
Burova, Elena ;
Hermann, Aynur ;
Waite, Janelle ;
Potocky, Terra ;
Lai, Venus ;
Hong, Seongwon ;
Liu, Matt ;
Allbritton, Omaira ;
Woodruff, Amy ;
Wu, Qi ;
D'Orvilliers, Amanda ;
Garnova, Elena ;
Rafique, Ashique ;
Poueymirou, William ;
Martin, Joel ;
Huang, Tammy ;
Skokos, Dimitris ;
Kantrowitz, Joel ;
Popke, Jon ;
Mohrs, Markus ;
MacDonald, Douglas ;
Ioffe, Ella ;
Olson, William ;
Lowy, Israel ;
Murphy, Andrew ;
Thurston, Gavin .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) :861-870
[4]   Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden [J].
Chalmers, Zachary R. ;
Connelly, Caitlin F. ;
Fabrizio, David ;
Gay, Laurie ;
Ali, Siraj M. ;
Ennis, Riley ;
Schrock, Alexa ;
Campbell, Brittany ;
Shlien, Adam ;
Chmielecki, Juliann ;
Huang, Franklin ;
He, Yuting ;
Sun, James ;
Tabori, Uri ;
Kennedy, Mark ;
Lieber, Daniel S. ;
Roels, Steven ;
White, Jared ;
Otto, Geoffrey A. ;
Ross, Jeffrey S. ;
Garraway, Levi ;
Miller, Vincent A. ;
Stephens, Phillip J. ;
Frampton, Garrett M. .
GENOME MEDICINE, 2017, 9
[5]   Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma [J].
Cranmer, Lee D. ;
Engelhardt, Candace ;
Morgan, Sherif S. .
ONCOLOGIST, 2010, 15 (12) :1320-1328
[6]   Microsatellite Instability as a Biomarker for PD-1 Blockade [J].
Dudley, Jonathan C. ;
Lin, Ming-Tseh ;
Le, Dung T. ;
Eshleman, James R. .
CLINICAL CANCER RESEARCH, 2016, 22 (04) :813-820
[7]   Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 [J].
Falchook, Gerald S. ;
Leidner, Rom ;
Stankevich, Elizabeth ;
Piening, Brian ;
Bifulco, Carlo ;
Lowy, Israel ;
Fury, Matthew G. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[8]   Cutaneous squamous cell carcinoma: an epidemiological review [J].
Green, A. C. ;
Olsen, C. M. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) :373-381
[9]  
Herman Sara, 2007, Skinmed, V6, P234, DOI 10.1111/j.1540-9740.2007.06174.x
[10]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723